Open AccessSemaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits
Author(s) -
Jorge Rico-Fontalvo,
Rodrigo Daza-Arnedo,
Jose Rafael Cabrales Juan,
Juan Montejo-Hernández
Publication year - 2022
Publication title -
revista colombiana de nefrología
Language(s) - English
Resource type - Journals
eISSN - 2500-5006
pISSN - 2389-7708
DOI - 10.22265/acnef.9.3.614
Subject(s) - semaglutide , medicine , albuminuria , overweight , diabetes mellitus , placebo , population , type 2 diabetes , obesity , liraglutide , endocrinology , urology , alternative medicine , environmental health , pathology